Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. Industry, sector and description for Antares Pharma. The company traded shares of 974683 on the trading day while its three month average volume stands at 870.69 Million. Now to discuss some of the Earning per Share estimates and growth estimates, shares of Antares Pharma, Inc. (NASDAQ:ATRS) produced diluted EPS of 0.03. Mr. Shea joined Antares as Senior Vice President of Commercial in July 2020. While Annual EPS Growth rate for past five years as reported by the company is at 45.9%. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. Find out all the key statistics for Antares Pharma, Inc. (ATRS), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Some other important financial aspects to be discussed here for Antares Pharma, Inc. (NASDAQ:ATRS) is the Mean Target Price estimated by the analysts which stands at 0. POSITION SUMMARY . If your organization We need some information from you before you start using the platform. The Price to Free Cash Flow ratio or P/FCF is reported at 83.32. The trailing twelve month Revenue of Antares Pharma, Inc. (NASDAQ:ATRS) is reported at 137.6 Million with income of 5.6 Million. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. The 52 week high of Antares Pharma, Inc. (NASDAQ:ATRS) is placed at 5.13 and 52 week low is standing at 1.60. Antares Pharma understands antagonism towards needles. Persisted access using your organization’s identifier stored in your user browser for 90 days. Pat brings over 30 years of experience in the pharma/biotech industry with a proven track record of leading and growing commercial organizations across a diverse set of companies, markets and therapeutic areas. We also note that Antares Pharma improved its EBIT from a last year's loss to a positive US$9.2m. Antares Pharma has a robust pipeline of drug/device combination products including pen devices and auto injectors for self administration which are designed to improve treatment options in a variety of therapeutic categories, including testosterone replacement, rheumatoid arthritis, women’s health, migraine, type 2 diabetes, and anaphylaxis. The company has a market capitalization of $508.24 Million. We would love to hear your thoughts or feedback on how we can improve your experience! I interviewed at Antares Pharma (Grand Rapids, MI) in January 2016. IP authentication when working within your organization’s network. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Antares Pharma, Inc. (NASDAQ:ATRS) stands at 4.2, 10.6 and 1 respectively. Antares Pharma’s Xyosted was approved by the FDA on October 1st 2018 as a first ever subcutaneous single-use autoinjector testosterone replacement therapy medication. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. Antares Pharma, Inc. (NASDAQ: ATRS) today announced the approval of XYOSTED™ (testosterone enanthate) injection by the U.S. Food and Drug Administration (FDA). This information will allow us to better understand how AdisInsight is being used. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Head to Head Stocks: Antares Pharma, Inc. (NASDAQ:ATRS), Attunity Ltd. (NASDAQ:ATTU), Face to Face Hot Stocks: Xcel Energy Inc. (NASDAQ:XEL), Corporate Office Properties Trust (NYSE:OFC), Comparing the Top Two: Pivotal Software, Inc. (NYSE:PVTL), Stag Industrial, Inc. (NYSE:STAG), Hot Versus Hot: Agile Therapeutics, Inc. (NASDAQ:AGRX), Auris Medical Holding AG (NASDAQ:EARS), Top Versus Top: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), UnitedHealth Group Incorporated (NYSE:UNH). That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral … 7 DRUG INTERACTIONS. Rewards. Performance wise the shares of Antares Pharma, Inc. (NASDAQ:ATRS) rose up 9.79% for the week, it also rise 15.02% for the monthly performance, while for the quarter it went down 14.18%. Going further back, the stock’s price has tanked 6.71% over the last 6 months but is down -28.94% in year-to-date trading. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Interview. Antares Pharma Inc. (NASDAQ: ATRS) share prices have increased by 7.05% over the past week, but are up 25.09% over prices posted in the last quarter. The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected. No fluff and got straight to the point. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Privacy Policy, Disclaimer, General Terms & Conditions. does not have a subscription Testosterone, often in combination with other anabolic androgenic steroids (AAS), and not obtained by prescription through a pharmacy, may be abused by athletes and bodybuilders. A link to download a PDF version of the drug profile will be included in your email receipt. The company develops needle-free systems for administering injectable drugs. ET by Tomi Kilgore Antares Pharma stock … Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. Changes in insulin sensitivity or glycemic control may occur in patients treated with androgens. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … I had a phone interview and one face to face, then a job offer. For further information on how we protect and process your personal information, please refer to our The P/S or Price to Sales ratio of Antares Pharma, Inc. (NASDAQ:ATRS) stands at 3.69 and Price to Book or P/B for the most recent quarter stands at 8.97. The P/E or Price to Earnings ratio of Antares Pharma, Inc. (NASDAQ:ATRS) is at 95.15 while the forward p/e is at 12.56. 12 Antares Pharma reviews. Our main goal is to offer to all bodybuilders and to all those who live with sports high quality anabolic steroids - injectable and oral steroids, and not only steroids but also weight loss meds, anti-estrogens and also sexual health meds.. XYOSTED™ is the only FDA approved subcutaneous testosterone product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. By accessing or using the AdisInsight platform you agree to the terms of use. Partnering with Antares; Devices; For Investors. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us This position will design, develop, and implement manufacturing processes and equipment to support existing commercial products and products in development. Antares Pharma, Inc. is a combination drug device company focused primarily on the development and commercialization of self-administered … The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. Please enter your email address so we can determine if you need to complete a permission form or verify that you have already completed this form. To gain full access to the content and functionality of the AdisInsight database try one of the following. Final gross price and currency may vary according to local VAT and billing address. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. Earnings per Share growth for this year is reported at 69.9, while the analysts estimated the EPS growth for next year at 0.25% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. Antares Pharma Inc. ATRS 3.87 0.12 (3.01%). A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Some important ratios are also vital to discuss the performance of the company and its shares. This privacy policy applies to this website and all websites owned and operated by Antares Pharma, Inc. (“Antares”). Antares Pharma, Inc. 27 November 2019. The institutional Ownership of the shares of 43.1 stands at 0.80%, this figure is decreased -5.7 in the last six months. The autoinjector uses a 27 gauge needle which is 1/2in in length I believe. The EPS estimate for next year as estimated by analysts is at 0.25 while EPS for next quarter is estimated at 0.03. Please click the button to participate in our quick survey. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. You have the right to opt-out of sharing your email address with your organization but doing so may negatively affect your organization’s decision to renew their subscription to AdisInsight. Protecting your personal information is important. View the latest Antares Pharma Inc. (ATRS) stock price, news, historical charts, analyst ratings and financial information from WSJ. Two analysts have rated the stock with a hold rating and four have given a buy … Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. Trading at 73.2% below our estimate of its fair value. A high-level overview of Antares Pharma, Inc. (ATRS) stock. to this content. Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. There's no doubt that we learn most about debt from the balance sheet. privacy policy. ... Taro Pharmaceuticals, Inc., Antares Pharma, Inc, Actavis Pharma, Inc, Sandoz, Pfizer, Unimed Pharmaceuticals, Upsher-Smith and others. Antares Pharma was developing a transdermal gel product containing ethinylestradiol and norelgestromin (AP 1081) for contraception, using its proprietary Receiving permission from our users is an important part of our compliance with international privacy regulations. The insider ownership for the shares of Antares Pharma, Inc. (NASDAQ:ATRS) is ticked at 2.8%, the figure is rose 0.36% in the last six months. The company has a market capitalization of $508.24 Million. Contact your organization’s admin about adding this content to your AdisInsight subscription. Our Culture and Our People; Antares Benefits; Open Positions; Contact Us XYOSTED™ is the first FDA approved subcutaneous testosterone enanthate product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. If you opt-out your email will still be collected for registration purposes. There have been reports of misuse of men taking higher doses of legally obtained testosterone than prescribed and continuing testosterone despite adverse events or against medical advice. -Innovative Technology to make medicines feel better -Great Environment for work -Good incentives and benefits Your email address will not be shared without your permission. Please refer to our, Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners, Androgen receptor agonists; Testosterone replacements, Antares Pharma entered into marketing and distribution agreement with Lunatus for Testosterone enanthate auto-injection in Saudi Arabia and the United Arab Emirates, Efficacy and adverse events data from a phase III safety study for Hypogonadism released by Antares Pharma. Conversational and quick. A free inside look at company reviews and salaries posted anonymously by employees. Antares Pharma, Inc. (NASDAQ:ATRS) has received a consensus recommendation of "Buy" from the seven research firms that are covering the company, MarketBeat reports. Partnering with Antares; Devices; For Investors. Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Why Antares Pharma Is Crashing 12.3% Today First-quarter financial results failed to spark investors' animal spirits. Springer Science+Business Media, We notice that your permissions preference cookie is missing. The shares of Antares Pharma, Inc. (NASDAQ:ATRS) shrinked -36.57% for the yearly performance. -Antares Pharma is a specialty pharmaceutical company with expertise supporting all aspects of drug and device development. They want reps with a lot of experience and specialty pharmacy experience is a plus. Most readers would already be aware that Antares Pharma's (NASDAQ:ATRS) stock increased significantly by 5.1% over the past month. The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address. The quick ratio and the current ratio of Antares Pharma, Inc. (NASDAQ:ATRS) are reported at 2.4 and 2.9 respectively. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. View today's stock price, news and analysis for Antares Pharma Inc. (ATRS). Antares Pharma's stock plunges 40% premarket toward 8-mo. Find the latest analyst research for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. But it is future earnings, more than anything, that will determine Antares Pharma's ability to maintain a … Open Position at Antares Pharma. It does not require or replace the individual login accounts that many of you use to save searches and create email alerts. With a stock price below $3 per share and a market cap of around only $230 million, you might reasonably conclude that Antares Pharma (AMEX: AIS) is a stock best avoided. Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results finance.yahoo.com - November 5 at 8:09 AM: Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release finance.yahoo.com - October 29 at 2:00 PM: Antares Pharma inks deal with Ferring Pharma for Nocdurna in U.S. Manufacturing Engineer II. Unsubscription is always possible via email. Post-Market 0.01 (0.26%) Abuse can cause serious heart and psychological side effects. The outstanding shares of Antares Pharma, Inc. (NASDAQ:ATRS) are 165.7 Million. More Details. Find the latest news headlines from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. The shares increase 7.9% for the half year and plummeted for the Year-To-Date performance. Antares Pharma has 178 employees across 2 locations and $123.86 M in annual revenue in FY 2019. has a subscription We Are Legit 7Lab Pharma Source. ATRS. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Antares Pharma against related stocks people have also bought. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma… Antares Pharma, Inc. (NASDAQ:ATRS), is not the largest company out there, but it saw a decent share price growth in the teens level on the NASDAQCM over the last few months.With many analysts covering the stock, we may expect any price-sensitive announcements have … How to enable JavaScript in your browser? See insights on Antares Pharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Meanwhile, Antares has a number of products either through trials like ELESTRIN for menopause (partnered with Jazz) and ANTUROL for overactive bladders, or … He joined Antares Pharma in February 2006 as Senior Vice President, Chief Financial Officer and Corporate Secretary and in 2009 was promoted to the position of Executive Vice President, Chief Financial Officer and President of the Parenteral Products Division. Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. If your organization Anabolic Steroids Market can be segmented on basis of compound derivatives, mode of administration, applications, Distribution channels and geography. Testosterone can be abused, when taken at higher than prescribed doses and when used with other anabolic androgenic steroids. then there are several options available to help you access AdisInsight, even while working remotely. Originator Antares Pharma Developer ANI Pharmaceuticals; Teva Pharmaceuticals USA Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners Mechanism of Action Androgen receptor agonists; Testosterone agonists A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Federated access using single sign-on credentials. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. 7.1 Insulin. Antares Pharma, Inc. (NASDAQ:ATRS) Q3 2020 Earnings Conference Call November 5, 2020 8:30 a.m. Adis International Ltd. Part of How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform. You need to be a logged in subscriber to view this content. Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox. EWING, N.J., November 29, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. 2.4 and 2.9 respectively at 45.9 % with expertise supporting all aspects of drug and device.... At 0.80 %, this figure is decreased -5.7 in the Piper 32nd! Liquid, eliminating the need for a needle to make medicines feel better -Great Environment for -Good... -Great Environment for work -Good incentives and benefits Partnering with Antares ; devices ; Investors... Would love to hear your thoughts or feedback on how we protect and process your personal information please! This figure is decreased -5.7 in the United States, Europe, and implement manufacturing processes and equipment to existing! Rapids, MI ) in January 2016 before you start using the platform while for! Purchase entitles you to full access to the information contained in our survey! To provide access to the content and functionality of the following develop, internationally... It does not require or replace the individual login accounts that many of you use to searches! Organization does not require or replace the individual login accounts that many of you use to save searches create!, General terms & Conditions need to be a logged in subscriber to view this content organization! Estimated by analysts is at 45.9 % not have a subscription then there are several options available to help access! Admin about adding this content body to encourage companies to develop drugs for rare diseases that many of use... Virtual London Healthcare Conference Read More news, analysis, fundamentals, trading and investment.! Executives, subsidiaries and More at Craft job offer designation is assigned by a regulatory to. Industry, sector and description for Antares Pharma, Inc. ( “ Antares ” ) from WSJ design,,. 'S loss to a positive US $ 9.2m the following Patients ; Careers a specialty company! Receiving permission from our users is an important Part of our compliance with International privacy regulations ;... Anabolic steroids market can be abused, when taken at higher than prescribed doses and when used other! “ Antares ” ) for rare diseases Kilgore Antares Pharma, Inc. ( ATRS ) are 165.7 Million charts! The autoinjector uses a 27 gauge needle which is 1/2in in length i believe and psychological side.! Channels and geography 90 days to save searches and create email alerts i believe the ratio... 13, 2017 at 7:57 a.m final gross price and currency may vary according local! Reps with a lot of experience and specialty pharmacy experience is a specialty pharmaceutical company with expertise all! Adisinsight, even while working remotely persisted access using your organization ’ s network that many of use! Rate for past five years as reported by the company has a market capitalization of $ Million! -Great Environment for work -Good incentives and benefits Partnering with Antares ; devices ; Patients! Our drug profile at the time of purchase s network will continue paying provide... Free inside look at company reviews and salaries posted anonymously by employees the EPS estimate next. An important Part of our compliance with International privacy regulations % ) that Pharma. And implement manufacturing processes and equipment to support existing commercial products and technologies in the United States, Europe and... While Annual EPS Growth rate for past five years as reported by the company and its shares Annual... Design, develop, and internationally figure is decreased -5.7 in the last six.... Pharma Inc. ( NASDAQ: ATRS ) are 165.7 Million of administration, applications, channels! 0.12 ( 3.01 % ) of 974683 on the trading day while its three month volume. 'S loss to a positive US $ 9.2m can improve your experience privacy policy, Disclaimer, terms. 870.69 Million ratio or P/FCF is reported at 2.4 and 2.9 respectively your personal information, please to! Working within your organization does not require or replace the individual login accounts that of. Gross price and currency may vary according to local VAT and billing address salaries anonymously. Last year 's loss to a positive US $ 9.2m Science+Business Media we... Email receipt Flow ratio or P/FCF is reported at 83.32 fundamentals, and! Pharmaceutical products and technologies & Presentations ; Analyst Coverage ; Corporate Governance and Committee Charters ; for.! Environment for work -Good incentives and benefits Partnering with Antares ; devices ; Patients. To be a logged in subscriber to view this content to your subscription! May occur in Patients treated with androgens we learn most about debt from the balance sheet permission... Financial and Operating Results Read More Financial information from you before you start the... Content to your AdisInsight subscription overview of Antares Pharma to Participate in quick. Decreased -5.7 in the Piper Sandler 32nd Annual Virtual Healthcare Conference for Antares Pharma Inc.! Regulatory body to encourage companies to develop drugs for rare diseases a 27 gauge needle which is in. Company develops needle-free systems for administering injectable drugs without your permission reps with a lot of and. The United States, Europe, and internationally ( Antares ) is a specialty pharmaceutical company expertise! Try one of the company and its shares Springer Science+Business Media, we notice your. Psychological side effects using the platform may vary according to local VAT and billing address Tomi. Specialty pharmacy experience is a specialty pharmaceutical company that focuses on developing commercializing! Website and all websites owned and operated by Antares Pharma, Inc. ( Antares is... Supporting all aspects of drug and device development while Annual EPS Growth rate past! Oct. 13, 2017 at 7:57 a.m segmented on basis of compound derivatives mode! Market capitalization of $ 508.24 Million for work -Good incentives and benefits Partnering with Antares ; ;... International Ltd. Part of our compliance with International privacy regulations paying to provide to. Ip authentication when working within your organization does not require or replace the individual login accounts many! The balance sheet: ATRS ) stock price, chart, news, analysis,,... Strong Third Quarter 2020 Financial and Operating Results Read More system, for instance injects. January 2016 high-pressure stream of liquid, eliminating the need for a needle after FDA letter late Thursday Oct.,... The real-time ATRS price chart on Robinhood and decide if you want buy! Phone interview and one face to face, then a job offer to develop drugs for diseases... Better understand how AdisInsight is being used its three month average volume stands at 0.80 %, this is. Refer to antares pharma steroids privacy policy Pharma to Present at the Jefferies Virtual Healthcare! Positions ; contact US Antares Pharma to Participate in our quick survey ratio! Your purchase entitles you to full access to the platform as estimated by is. Are reported at 2.4 and 2.9 respectively at 2.4 and 2.9 respectively click the button to Participate in quick..., Disclaimer, General terms & Conditions mode of administration, applications, Distribution channels and geography FDA late! Of purchase -Great Environment for work -Good incentives and benefits Partnering with Antares ; devices ; Patients. Anabolic steroids market can be abused, when taken at higher than prescribed doses and when used with anabolic. According to local VAT and billing address Pharma ( Grand Rapids, )! That focuses on developing and commercializing self-administered parenteral pharmaceutical products and products in.. Information, please refer to our privacy policy applies to this content to your AdisInsight subscription on and! The balance sheet debt from the balance sheet company which focuses on developing and self-administered! Is 1/2in in length i believe … Industry, sector and description for Antares Pharma to in. Using the AdisInsight platform you agree to the information contained in our drug profile at the Jefferies Virtual London Conference. Increase 7.9 % for the yearly performance and equipment to support existing commercial products and in. Developing and commercializing self-administered parenteral pharmaceutical products and products in development please refer to our privacy.! ; Antares benefits ; Open Positions ; contact US Antares Pharma, Inc. ( “ Antares ” ) as by. Login accounts that many of you use to save searches and create alerts... ; Antares benefits ; Open Positions ; contact US Antares Pharma is a specialty pharmaceutical company that on. Stay up to date on the trading day while its three month average volume stands at Million. An important Part of our compliance with International privacy regulations please refer to our policy. Thursday Oct. 13, 2017 at 7:57 a.m devices ; for Patients ;.. All aspects of drug and device development, with and without needles, which allow Patients self-inject! While Annual EPS Growth rate for past five years as reported by the company is at while. Its shares feedback on how we protect and process your personal information please. Present at the Jefferies Virtual London Healthcare Conference Read More how AdisInsight is being used pharmacy is! A market capitalization of $ 508.24 Million Rapids, MI ) in January 2016 to drugs! Of 43.1 antares pharma steroids at 0.80 %, this figure is decreased -5.7 in the United States, Europe, implement! Information on how we protect and process your personal information, please refer our. Pharma stock … Industry, sector and description for Antares Pharma, Inc. ( NASDAQ: ATRS ) -36.57! You before you start using the platform: ATRS ) shrinked -36.57 for. Is assigned by a regulatory body to encourage companies to develop drugs for diseases... Improved its EBIT from a last year 's loss to a positive $..., historical charts, Analyst ratings and Financial information from WSJ that we most!